IL-21, a cytokine implicated in CD8+ Tfc-like responses, peaked at 3 weeks but was absent at 6 weeks, suggesting transient CD8+ Tfc activation that is often associated with B cell help and early tumor immune surveillance46. The gene discussed is CD8A; the disease is neoplasm.